Evidence map›Paper›PMID 38813649›Full record

ArticleEmerging microbes & infections2024

Tracing the evolution of the chikungunya virus in Argentina, 2016-2023: independent introductions and prominence of Latin American lineages.

Cintia Fabbri, Marta Giovanetti, Victoria Luppo, Vagner Fonseca, Jorge Garcia, Cintia Barulli, Mariel Feroci, Sofia Perrone, Doraldina Casoni, Sergio Giamperetti and 16 more

Abstract read
In one paragraph

Article in Emerging microbes & infections, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Nanopore Sequencing for Chikungunya Virus: Principles and Application.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Cintia FabbriInstituto Nacional de Enfermedaes Virales Humanas "Dr. Maiztegui", ANLIS, Pergamino, Argentina.
Marta GiovanettiDepartment of Sciences and Technologies for Sustainable Development and One Health, Universita Campus Bio-Medico di Roma, Rome, Italy.
Victoria LuppoInstituto Nacional de Enfermedaes Virales Humanas "Dr. Maiztegui", ANLIS, Pergamino, Argentina.
Vagner FonsecaClimate Amplified Diseases and Epidemics (CLIMADE), Minas Gerais, Brazil.
Jorge GarciaInstituto Nacional de Enfermedaes Virales Humanas "Dr. Maiztegui", ANLIS, Pergamino, Argentina.
Cintia BarulliInstituto Nacional de Enfermedaes Virales Humanas "Dr. Maiztegui", ANLIS, Pergamino, Argentina.
Mariel FerociInstituto Nacional de Enfermedaes Virales Humanas "Dr. Maiztegui", ANLIS, Pergamino, Argentina.
Sofia PerroneInstituto Nacional de Enfermedaes Virales Humanas "Dr. Maiztegui", ANLIS, Pergamino, Argentina.
Doraldina CasoniInstituto Nacional de Enfermedaes Virales Humanas "Dr. Maiztegui", ANLIS, Pergamino, Argentina.
Sergio GiamperettiHospital de Infecciosas Francisco Javier Muñiz, CABA, Buenos Aires, Argentina.
Maria Cristina Alvarez LopezHospital General de Niños R. Gutiérrez, CABA, Buenos Aires, Argentina.
Maria Delia FoussalHospital Julio C. Perrando, Chaco, Argentina.
Mauricio FigueredoHospital de Alta Complejidad "Pte. Juan Domingo Perón", Formosa, Argentina.
Karina SalvatierraLaboratorio de Alta Complejidad de Posadas, Misiones, Argentina.
Sergio LejonaCEMAR - Secretaria de Salud - Municipalidad de Rosario, Santa Fe, Argentina.
Natalia Ruiz DiazLaboratorio Central de Redes y Programas de Corrientes, Corrientes, Argentina.
Gonzalo CastroLaboratorio Central de la Provincia de Cordoba, Córdoba, Argentina.
Gabriela BravoHospital Señor del Milagro, Salta, Argentina.
Noelia JackelInstituto Nacional de Enfermedaes Virales Humanas "Dr. Maiztegui", ANLIS, Pergamino, Argentina.
Carina SenInstituto Nacional de Enfermedaes Virales Humanas "Dr. Maiztegui", ANLIS, Pergamino, Argentina.
Tomás Poklepovich CarideUnidad Operativa, Centro Nacional de Genómica y Bioinformática, ANLIS.
Leticia FrancoInfectious Hazards Management, Health Emergencies Department (PHE), Pan American Health Organi-zation/World Health Organization (PAHO/WHO), Washington, DC, USA.
Carlos GiovachiniDireccion de Epidemiologia, Minsiterio de Salud de la Nacion, Buenos Aires, Argentina.
Jairo Mendez RicoInfectious Hazards Management, Health Emergencies Department (PHE), Pan American Health Organi-zation/World Health Organization (PAHO/WHO), Washington, DC, USA.
Luiz Carlos Junior AlcantaraInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
Maria Alejandra MoralesInstituto Nacional de Enfermedaes Virales Humanas "Dr. Maiztegui", ANLIS, Pergamino, Argentina.

Funding

University of Washington Arboviral Research Network (UWARN)U01AI151698 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale, PETER MACGARR RABINOWITZ · 2020 to 2026
$13.3M
NIAID NIH HHS U01 AI151698World Health Organization 001
6 · The paper itself

Abstract

Chikungunya virus (CHIKV) has emerged as a significant public health concern due to its rapid spread and potential for causing debilitating epidemics. In Argentina, the virus has garnered attention since its introduction to the Americas in 2013, due to its growing incidence and impact in neighbouring countries. Here we present a comprehensive analysis of the spatiotemporal dynamics of CHIKV in Argentina, focusing on the evolutionary trajectory of its genetic variants. Through a combination of active surveillance, screening of historical and recent samples, and whole-genome sequencing, we traced the evolutionary history of CHIKV lineages circulating within the country. Our results reveal that two distinct genotypes circulated in Argentina: The Asian lineage during the 2016 epidemic and the ECSA lineage in 2023. This distribution reflects the dominance of particular variants across Latin America. Since 2023, the ECSA lineage has led to a surge in cases throughout the Americas, marking a significant shift. The replacement of lineages in the American region constitutes a major epidemiological event, potentially affecting the dynamics of virus transmission and the clinical outcomes in impacted populations. The spatiotemporal analysis highlights CHIKV's distribution across Argentina and underscores the significant role of human mobility, especially when considering recent epidemics in neighbouring countries such as Paraguay and Uruguay, which have facilitated the spread and introduction of the viral strain into different districts. By integrating epidemiological data with genomic insights, we elucidate the patterns of virus dissemination, highlighting key areas of transmission and potential factors contributing to its spread.

Indexed as

Chikungunya FeverChikungunya virusEvolution, MolecularGenotypePhylogenyArgentinaGenetic VariationGenome, ViralHumansLatin AmericaSpatio-Temporal AnalysisWhole Genome SequencingArgentinaCHIKVevolutiongenomic surveillancemolecular epidemiologyphylodynamic

Identifiers

PMID38813649
PMCPMC11168220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.